Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DSCR10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100505666 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R3E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC102724537 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
COL7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPHS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM95A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPRD1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TKFC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR176 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFCAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on